Range
15.96 - 16.5
Vol / Avg.
19.9K/229K
Div / Yield
-
52 Wk
10.44 - 25.19
Mkt Cap
280.1M
Payout Ratio
-
Open
16.5
P/E
-
EPS
-2.21
Shares
17.3M
Outstanding
17.3M
Total Float
17.3M
Sector: Health Care.Industry: Biotechnology
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001, is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-09
REV
Q2 2021Est.ActualSurprise
EPS-1.520-2.210 -0.6900
REV1.090M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Viridian Therapeutics Questions & Anwsers

Q

How do I buy Viridian Therapeutics (VRDN) stock?

A

You can purchase shares of Viridian Therapeutics (NASDAQ: VRDN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Viridian Therapeutics's (VRDN) competitors?

Q

What is the target price for Viridian Therapeutics (VRDN) stock?

A

The latest price target for Viridian Therapeutics (NASDAQ: VRDN) was reported by Evercore ISI Group on October 12, 2021. The analyst firm set a price target for 40.00 expecting VRDN to rise to within 12 months (a possible 147.22% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Viridian Therapeutics (VRDN)?

A

The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $16.18 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Viridian Therapeutics (VRDN) pay a dividend?

A

There are no upcoming dividends for Viridian Therapeutics.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics’s $Q3 earnings are confirmed for after-market on $November 9, 2021.

Q

Is Viridian Therapeutics (VRDN) going to split?

A

There is no upcoming split for Viridian Therapeutics.

Q

What sector and industry does Viridian Therapeutics (VRDN) operate in?

A

Viridian Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.